Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
EUR 4M - 4M
Notice Type:
Contract award notice
Published Date:
02 March 2021
Closing Date:
Location(s):
FRJ LANGUEDOC-ROUSSILLON-MIDI-PYRÉNÉES (FR FRANCE)
Description:
Produits de santé: fournitures de médicaments pour les années 2021 à 2024 (36 mois)

Accord-cadre de fournitures de médicaments à compter du 1.4.2021 à 2024 (36 mois) — quatorze lots.


Alfentanil inj.

Alfentanil inj. ampoule 2 ml et 10 ml.


Micafungine inj.

Micafungine 50 mg et 100 mg.


Mitomycine C 40 mg inj.

Mitomycine C 40 mg inj.


Oxybate de sodium suspension buvable

Oxybate de sodium suspension buvable à 500 mg/ml flacon de 180 ml.


Paclitaxel albumine 100 mg inj.

Paclitaxel albumine 100 mg inj.


Thalidomide oral

Thalidomide oral 50 mg.


Ambrisentan oral

Ambrisentan oral comprimé 5 mg et 10 mg.


Atovaquone susp. buv.

Atovaquone susp. buv. à 750 mg/5 ml flacon de 240 ml.


Bévacizumab inj.

Bévacizumab inj. solution à diluer 100 mg et 400 mg.


Cinacalcet oral

Cinacalcet oral comprimé 30 mg, 60 mg et 90 mg.


Divalproate de sodium oral

Divalproate de sodium oral comprimé 250 mg et 500 mg.


Erlotinib oral

Erlotinib oral comprimé 25 mg, 100 mg et 150 mg.


Foscarnet inj.

Foscarnet inj. 6 g/250 ml solution pour perfusion.


Iloprost inj.

Iloprost inj. solution injectable à diluer pour perfusion à 0,1 mg/1 ml.

Awarded to:
Thalidomide oral
Accord healthcare, Lille (FR)
Cinacalcet oral
Arrow Génériques, Lyon (FR)
Atovaquone ssuspension buvable
Biogaran, Paris (FR)
Alfentanil inj.
CSP, Cournon (FR)
Foscarnet inj.
Fresenius Kabi France, Sèvres (FR)
Mitomycine C 40 mg inj.
Medac, Lyon (FR)
Bévacizumab inj.
MSD France, Paris (FR)
Erlotinib oral
Mylan SAS, Saint-Priest (FR)
Micafungine inj.
Ohre Pharma, Mitry-Mory (FR)
Divalproate de sodium oral
Sanofi Aventis, Gentilly (FR)
Ambrisentan oral
Teva, Paris (FR)
Iloprost inj.
Teva, Paris (FR)
Oxybate de sodium suspension buvable
UCB Pharma chez CSP, Colombes (FR)
Download full details as .pdf
The Buyer:
Centre hospitalier de Cahors
CPV Code(s):
33600000 - Pharmaceutical products
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33640000 - Medicinal products for the genitourinary system and hormones
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
33660000 - Medicinal products for the nervous system and sensory organs
33670000 - Medicinal products for the respiratory system